| |
|
| |
|
Diagnostic Process
A number of medical and psychiatric conditions may cause or contribute to cognitive impairment in older adults. It is vital to identify and aggressively treat any potentially reversible causes of cognitive impairment. The table below lists a number of reversible causes of cognitive impairment.
| Potentially Reversible Causes of Cognitive Impairment in the Elderly |
|
adapted from reference 2
Because of considerable symptom overlap, it can be difficult to differentiate between dementia, depression, and delirium.
|
|
Dementia | Depression | Delirium |
| Level of consciousness | Alert | Alert | Waxes/wanes |
| Course | Chronic | Chronic or acute | Acute |
| Other Features | Neuro-vegetative state | Medical causes |
It is not unusual for delirium to be superimposed on a dementing process, further complicating diagnosis. Clinicians should maintain a high index of suspicion for delirium when assessing significant cognitive decline in a patient with pre-existing dementia. Dementia appears to predispose toward development of delirium often as a result of seemingly inconsequential insults such as urinary tract infections or use of CNS active medications.
Although AD is the most common diagnosis associated with cognitive impairment in the elderly, the etiology of other types of dementing conditions must also be considered during the assessment process. Among the dementing disorders, vascular dementia follows AD as the second most common form. From the Cache county study that identified 324 community dwelling individuals with cognitive impairment, vascular dementia was diagnosed in 19%, in contrast to 65% of subjects identified with AD.
![]() |
|
source: Cache County Study on Memory and Aging: Prevalence of major types of dementia.4
| Vascular dementia is generally characterized by a relatively acute onset that is related to an event such as a CVA or TIA and appears to have a more "step-wise" progression as compared with the gradual decline associated with AD.The Hachinski scale can be used to assess for the likelihood of vascular dementia. Cerebral ischemic pathology may also coexist with AD, resulting in what is referred to as "mixed dementia". This type of diagnosis was thought to be relatively uncommon until the publication of the 1997 Nun Study.6
|
![]() |
It is often stated that a definitive diagnosis of AD can be made only with a brain biopsy or an autopsy - this statement tends to instill an unnecessary sense of diagnostic nihilism. While it is true that the neuropathological changes associated with AD can only be identified by brain tissue examination, researchers have made significant progress in developing accurate diagnostic tests and criteria for the clinical diagnosis of AD. A growing number of guidelines and diagnostic algorithms are available for use by clinicians; use of standardized criteria is thought to greatly improve diagnostic accuracy. One study demonstrated up to 90% diagnostic accuracy for AD utilizing specialized cognitive testing in combination with medical and neurological evaluation.7
The "gold standard" of diagnostic criteria is the National Institute of Neurological and Related and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders Association for diagnosis of possible and probable AD.
The Diagnostic and Statistical Manual (DSM IV) criteria are also commonly used in clinical practice.
| DSM
IV Diagnostic criteria for dementia of the Alzheimer's type |
|
The diagnostic evaluation for dementia includes the following components:

| A | B | |
![]() |
![]() |
|
| MRI scan in patients with mild (A) and moderate (B) AD. Ventricular enlargement (blue arrow) and cortical atrophy (red arrow) are more prominent in the patient with moderate disease. Adapted from reference2. | ||
Value of routine procedure continues to be controversial
Computed tomography (CT) scan without contrast
useful to rule out 
Magnetic resonance imaging (MRI) is more costly, but better for visualizing
Positron emission tomography (PET) or single photon emission computed tomography (SPECT) are very costly and not widely available for routine clinical use. PET and SPECT scans may have utility in differentiating between certain types of non-reversible dementias
![]() |
| PET scans of a healthy elderly person and a patient with Alzheimer's disease. PET scan of person with AD (right) has large dark areas of limited brain activity, which contrast with reflecting brain activity in non-AD patient. |
Staging:
After diagnosis, persons with AD are often evaluated by staging criteria. To use staging criteria, level of functioning in multiple areas is assessed and the category that most closely describes the individual's characteristics is chosen. The 7 stage Global Deterioration Scale (GDS)9 is a tool to measure global functional changes in AD and is commonly utilized in clinical practice. Since the course of AD is extremely variable, there are no standard time periods given for each stage.